MarketCapTrends
CPHI
China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare

China Pharma Holdings Inc. Total Liabilities 2010–2025

China Pharma Holdings Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • China Pharma Holdings Inc. total liabilities for the quarter ending December 31, 2025 were 8.3M, a 15.69% increase year-over-year.
  • China Pharma Holdings Inc. total liabilities for 2025 were 8.3M, a 15.69% increase from 2024.
  • China Pharma Holdings Inc. total liabilities for 2024 were 7.1M, a 20.80% decrease from 2023.
  • China Pharma Holdings Inc. total liabilities for 2023 were 9.0M, a 33.20% decrease from 2022.
  • China Pharma Holdings Inc. total liabilities for 2022 were 13.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
China Pharma Holdings Inc. Annual Total Liabilities (Millions of US $)
2025$8
2024$7
2023$9
2022$13
2021$17
2020$13
2019$13
2018$15
2017$17
2016$20
2015$24
2014$28
2013$25
2012$15
2011$14
China Pharma Holdings Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$8
2024-12-31$7
2023-12-31$9
2022-12-31$13
2021-12-31$17
2020-12-31$13
2019-12-31$13
2018-12-31$15
2017-12-31$17
2016-12-31$20
2015-12-31$24
2014-12-31$28
2013-12-31$25
2012-12-31$15
2011-12-31$14
2010-12-31$14

China Pharma Holdings Inc. Total Liabilities — FAQ

China Pharma Holdings Inc. (CPHI) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CPHI's total liabilities history?

The chart and table above show China Pharma Holdings Inc.'s total liabilities by year and by quarter, including the growth rate.